Search Results - "Chesnokova, L. Yu"

  • Showing 1 - 6 results of 6
Refine Results
  1. 1

    The Use of Levosimendan for the Treatment of Heart Failure and its Potential Organoprotective Effects by Lebedeva, N. B., Chesnokova, L. Yu

    “…The review article is aimed at providing a recent update on the use of levosimendan, an inotropic drug in current use for the treatment of heart failure. The…”
    Get full text
    Journal Article
  2. 2

    Effect of levosimendan on long-term prognosis in patients with myocardial infarction and concomitant chronic brain ischemia by Lebedeva, N. B., Chesnokova, L. Yu, Barbarash, O. L.

    Published in Rossiĭskiĭ kardiologicheskiĭ zhurnal (17-02-2021)
    “…Aim. To study the effect of levosimendan (LS) on 1-year prognosis in patients with myocardial infarction (MI), complicated with heart failure (HF), and…”
    Get full text
    Journal Article
  3. 3
  4. 4

    OPTIMIZATION OF THE TREATMENT OF ELDERLY PATIENTS WITH MYOCARDIAL INFARCTION BY REVASCULARIZATION IN COMBINATION WITH INOTROPIC STIMULATION AND MYOCARDIAL UNLOADING by Krivonosov, D. S., Chesnokova, L. Yu, Tarasov, N. I.

    “…Aim. To study effect of coronary revascularization in combination with inotropic stimulation and myocardial unloading on prognosis in elderly patients with…”
    Get full text
    Journal Article
  5. 5

    FACTORS ASSOCIATED WITH THE SEVERITY OF CHRONIC CEREBRAL ISCHEMIA IN PATIENTS WITH MYOCARDIAL INFARCTION COMPLICATED BY LEFT VENTRICULAR FAILURE by L. Yu. Chesnokova, N. B. Lebedeva, N. I. Tarasov

    Published in Ateroskleroz (01-03-2019)
    “…We aimed to analyze the factors determining a severity degree of cerebral pathology in patients with myocardial infarction complicated with left ventricular…”
    Get full text
    Journal Article
  6. 6

    Pulmonary involvement in patients with hypertensive disease by Barbarash, O L, Rutkovskaia, N V, Smakotina, S A, Chesnokova, Iu L, Bazdyrev, E V, Cherniavskaia, E Iu, Kudriavtseva, I A

    Published in Kardiologiia (2010)
    “…Parameters of spirometry, body plethysmography, and pulmonary diffusion capacity were measured in 46 patients (age 35-60 years, 40 men, 6 women) with stage…”
    Get more information
    Journal Article